Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain
Lynn Webster; Jan Peter Jansen; John Peppin; Ben Lasko; Gordon Irving; Bart Morlion; Jerry Snidow; Amy Pierce; Eric Mortensen; Christi Kleoudis; Eric Carter
- 作者Lynn Webster; Jan Peter Jansen; John Peppin; Ben Lasko; Gordon Irving; Bart Morlion; Jerry Snidow; Amy Pierce; Eric Mortensen; Christi Kleoudis; Eric Carter
- 卷第137卷
- 期第2期
- 印刷ISSN0304-3959
- 电子ISSN1872-6623
- 文件大小722.96KB
- 发表时间2008
- DOI10.1016/j.pain.2007.11.008